369 related articles for article (PubMed ID: 17283139)
1. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
Krelin Y; Voronov E; Dotan S; Elkabets M; Reich E; Fogel M; Huszar M; Iwakura Y; Segal S; Dinarello CA; Apte RN
Cancer Res; 2007 Feb; 67(3):1062-71. PubMed ID: 17283139
[TBL] [Abstract][Full Text] [Related]
2. Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells.
Elkabets M; Krelin Y; Dotan S; Cerwenka A; Porgador A; Lichtenstein RG; White MR; Zoller M; Iwakura Y; Dinarello CA; Voronov E; Apte RN
J Immunol; 2009 Apr; 182(8):4874-81. PubMed ID: 19342666
[TBL] [Abstract][Full Text] [Related]
3. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.
Kafka D; Ling E; Feldman G; Benharroch D; Voronov E; Givon-Lavi N; Iwakura Y; Dagan R; Apte RN; Mizrachi-Nebenzahl Y
Int Immunol; 2008 Sep; 20(9):1139-46. PubMed ID: 18596024
[TBL] [Abstract][Full Text] [Related]
4. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice.
Voronov E; Dotan S; Gayvoronsky L; White RM; Cohen I; Krelin Y; Benchetrit F; Elkabets M; Huszar M; El-On J; Apte RN
Int Immunol; 2010 Apr; 22(4):245-57. PubMed ID: 20181656
[TBL] [Abstract][Full Text] [Related]
5. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
[TBL] [Abstract][Full Text] [Related]
6. Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I.
Joosten LA; Van De Veerdonk FL; Vonk AG; Boerman OC; Keuter M; Fantuzzi G; Verschueren I; Van Der Poll T; Dinarello CA; Kullberg BJ; Van Der Meer JW; Netea MG
APMIS; 2010 Dec; 118(12):1000-7. PubMed ID: 21091783
[TBL] [Abstract][Full Text] [Related]
7. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
8. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
Lu P; Li L; Liu G; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
[TBL] [Abstract][Full Text] [Related]
9. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.
Apte RN; Dotan S; Elkabets M; White MR; Reich E; Carmi Y; Song X; Dvozkin T; Krelin Y; Voronov E
Cancer Metastasis Rev; 2006 Sep; 25(3):387-408. PubMed ID: 17043764
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction.
Weiss T; Vitacolonna M; Zöller M
J Immunother; 2009; 32(6):552-64. PubMed ID: 19483654
[TBL] [Abstract][Full Text] [Related]
12. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
Nambu A; Nakae S; Iwakura Y
Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
[TBL] [Abstract][Full Text] [Related]
13. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
[TBL] [Abstract][Full Text] [Related]
14. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.
Apte RN; Krelin Y; Song X; Dotan S; Recih E; Elkabets M; Carmi Y; Dvorkin T; White RM; Gayvoronsky L; Segal S; Voronov E
Eur J Cancer; 2006 Apr; 42(6):751-9. PubMed ID: 16530403
[TBL] [Abstract][Full Text] [Related]
15. Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.
Dvorkin T; Song X; Argov S; White RM; Zoller M; Segal S; Dinarello CA; Voronov E; Apte RN
J Leukoc Biol; 2006 Jul; 80(1):96-106. PubMed ID: 16707560
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.
Koenders MI; Devesa I; Marijnissen RJ; Abdollahi-Roodsaz S; Boots AM; Walgreen B; di Padova FE; Nicklin MJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2008 Nov; 58(11):3461-70. PubMed ID: 18975337
[TBL] [Abstract][Full Text] [Related]
17. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
[TBL] [Abstract][Full Text] [Related]
18. IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation.
Rider P; Carmi Y; Guttman O; Braiman A; Cohen I; Voronov E; White MR; Dinarello CA; Apte RN
J Immunol; 2011 Nov; 187(9):4835-43. PubMed ID: 21930960
[TBL] [Abstract][Full Text] [Related]
19. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury.
Furuichi K; Wada T; Iwata Y; Kokubo S; Hara A; Yamahana J; Sugaya T; Iwakura Y; Matsushima K; Asano M; Yokoyama H; Kaneko S
Crit Care Med; 2006 Sep; 34(9):2447-55. PubMed ID: 16849996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
